AGT and hematocrit: Apigenin (50–100 mg/kg; p.o. for 4 weeks) reduced the level of FFAs in serum and myocardial tissue, cardiomyocyte cross-sectional area, and improved HT, heart weight, and serum AngII in rats with renovascular HT.